However, a study of Chinese breast cancer patients indicates that CEA and CA15‐3 levels are elevated in only 7.2% and 12.3% of these patients, respectively (Garcia‐Murillas et al., 2015). The gene discussed is CEACAM5; the disease is breast carcinoma.